Active bmn 111: daily subcutaneous injection of 15 ug/kg of bmn 111    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
276軟骨無形成症1

276. 軟骨無形成症 [臨床試験数:37,薬物数:29(DrugBank:6),標的遺伝子数:4,標的パスウェイ数:25
Searched query = "Achondroplasia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 37 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03989947
(ClinicalTrials.gov)
June 12, 201922/5/2019An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With AchondroplasiaA Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With AchondroplasiaAchondroplasiaDrug: Active BMN 111: Daily subcutaneous injection of 15 ug/kg of BMN 111BioMarin PharmaceuticalNULLEnrolling by invitation15 MonthsN/AAll70Phase 2United States;Australia;Japan;United Kingdom